FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 302:6-10 January 3, 1980 Number 1 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We altered platelet cholesterol by incubating the cells with either "cholesterol-rich" or "cholesterol-poor" liposomes. These platelets were then used to study the influence of cholesterol content on the metabolism of arachidonic acid, a fatty acid that serves as the critical precursor in the platelet for formation of the potent aggregating agent thromboxane A2. After addition of the aggregating agent thrombin, cholesterol-enriched platelets released 18.1 +/- 0.6 per cent (mean +/- 1 S.E.M.) [14C]arachidonic acid from prelabeled platelet phospholipids. This value was higher (P less than 0.001) than that for cholesterol-depleted platelets (14.6 +/- 1.0 per cent). Conversion of released arachidonic acid to platelet thromboxane B2 (the stable end product of thromboxane A2) was also higher in cholesterol-rich platelets (22.6 +/- 3.9 per cent) than in cholesterol-depleted platelets (13.8 +/- 2.7 per cent). These studies show that changes in the cholesterol content of human platelets in vitro have a significant effect on platelt metabolism of arachidonic acid. N Engl J Med 302:6-10, 1980).

This article has been cited by other articles:

• Lazar, H. L. (2004). Role of statin therapy in the coronary bypass patient. Ann. Thorac. Surg. 78: 730-740 [Abstract] [Full Text]  
• Waters, D.D., Khush, K.K. (2004). Management of the acute coronary syndrome patient. Eur Heart J Suppl 6: C49-C57 [Abstract] [Full Text]  
• Prasad, K., Lee, P. (2003). Suppression of Oxidative Stress as a Mechanism of Reduction of Hypercholesterolemic Atherosclerosis by Aspirin. J CARDIOVASC PHARMACOL THER 8: 61-69 [Abstract]  
• Hackeng, C. M., Huigsloot, M., Pladet, M. W., Nieuwenhuis, H. K., van Rijn, H. J. M., Akkerman, J.-W. N. (1999). Low-Density Lipoprotein Enhances Platelet Secretion Via Integrin-{alpha}IIbß3–Mediated Signaling. Arterioscler. Thromb. Vasc. Bio. 19: 239-247 [Abstract] [Full Text]  
• Rodrigueza, W. V., Mazany, K. D., Essenburg, A. D., Pape, M. E., Rea, T. J., Bisgaier, C. L., Williams, K. J. (1997). Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools : Implications for the Treatment of Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 17: 2132-2139 [Abstract] [Full Text]  
• Chen, L.Y., Mehta, P., Mehta, J.L. (1996). Oxidized LDL Decreases L-Arginine Uptake and Nitric Oxide Synthase Protein Expression in Human Platelets : Relevance of the Effect of Oxidized LDL on Platelet Function. Circulation 93: 1740-1746 [Abstract] [Full Text]  
• Lacoste, L., Lam, J. Y.T., Hung, J., Letchacovski, G., Solymoss, C. B., Waters, D. (1995). Hyperlipidemia and Coronary Disease : Correction of the Increased Thrombogenic Potential With Cholesterol Reduction. Circulation 92: 3172-3177 [Abstract] [Full Text]  
• Notarbartolo, A., Davi, G., Averna, M., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. P. L., Patrono, C. (1995). Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa Hypercholesterolemia. Arterioscler. Thromb. Vasc. Bio. 15: 247-251 [Abstract] [Full Text]  
• Prasad, K., Kalra, J. (1989). Experimental Atherosclerosis and Oxygen Free Radicals. ANGIOLOGY 40: 835-843 [Abstract]  
• Levine, P. H., Fisher, M., Schneider, P. B., Whitten, R. H., Weiner, B. H., Ockene, I. S., Johnson, B. F., Johnson, M. H., Doyle, E. M., Riendeau, P. A., Hoogasian, J. J. (1989). Dietary Supplementation With Omega-3 Fatty Acids Prolongs Platelet Survival in Hyperlipidemic Patients With Atherosclerosis. Arch Intern Med 149: 1113-1116 [Abstract]  
• Fisher, M., Levine, P. H., Weiner, B., Ockene, I. S., Johnson, B., Johnson, M. H., Natale, A. M., Vaudreuil, C. H., Hoogasian, J. (1986). The Effect of Vegetarian Diets on Plasma Lipid and Platelet Levels. Arch Intern Med 146: 1193-1197 [Abstract]  
• Zucker, M. L., Trowbridge, C., Woodroof, J., Chernoff, S. B., Reynoso, L., Dujovne, C. A. (1986). Low- vs High-Dose Aspirin: Effects on Platelet Function in Hyperlipoproteinemic and Normal Subjects. Arch Intern Med 146: 921-925 [Abstract]  
• SCHAFER, A. I. (1985). The Hypercoagulable States. ANN INTERN MED 102: 814-828 [Abstract]  
• PITT, B., SHEA, M. J., ROMSON, J. L., LUCCHESI, B. R. (1983). Prostaglandins and Prostaglandin Inhibitors in Ischemic Heart Disease. ANN INTERN MED 99: 83-92 [Abstract]  
• Ornish, D., Scherwitz, L. W., Doody, R. S., Kesten, D., McLanahan, S. M., Brown, S. E., DePuey, E. G., Sonnemaker, R., Haynes, C., Lester, J., McAllister, G. K., Hall, R. J., Burdine, J. A., Gotto, A. M. Jr (1983). Effects of Stress Management Training and Dietary Changes in Treating Ischemic Heart Disease. JAMA 249: 54-59 [Abstract]